Questions and answers regarding the use of rivaroxaban in daily practice.
PubMed ID
23882916
Abstract
Several new oral anticoagulants are now on the Swiss market and the general practitioner faces new challenges regarding the management of these new drugs. This consensus document aims to answer to the most frequently asked questions regarding rivaroxaban and covers different topics such as indications, initiation of treatment, drug-drug interactions and perioperative management.
Date Issued
2013-06-26
Publication Type
Article
Subject(s)
Language(s)
fr
Author(s)
Additional Credits
Journal
Revue médicale suisse
Publisher
Médecine & Hygiène
ISSN
0025-6749
Access(Rights)
metadata.only